Matthias Sturm, spokesman for Boehringer Ingelheim RCV, referred to a media briefing scheduled for April 1. According to the state, the company will settle in the ecoplus business park in Bruck ad Leitha, where a plot of land has already been purchased.
Just last October, Boehringer Ingelheim opened a new biotech plant in Vienna after four years of construction. More than 700 million euros were invested in the Vienna-Meidling location, and around 500 additional jobs were created.
Boehringer Ingelheim was founded in 1885 by Albert Boehringer in Ingelheim am Rhein. It is the largest research-based pharmaceutical company in Germany. The core business is researching, developing, manufacturing and selling medicinal products for humans and animals.
The project met with great approval on Friday in Lower Austria. The federal state “applied for this production facility in a complex process and prevailed against locations in America, Germany and Spain,” emphasized Mikl-Leitner in a broadcast. Provincial Councilor Jochen Danninger (ÖVP) spoke with regard to the settlement in the ecoplus business park that pharmaceutical companies in Lower Austria are offered a “perfect environment”.
“With the settlement of BoehringerIngelheim we have achieved a milestone in positioning ourselves as an innovative business location in the eastern region,” emphasized the mayor of Bruck an der Leitha, Gerhard Weil (SPÖ). All wheels are turning towards the sustainable development of the city, he said in a statement.